Clinical studies have shown that the concentration of PRL is elevated in the serum of patients with Parkinson’s disease [91] and in the cerebrospinal fluid of patients with Alzheimer’s disease with low Aβ1-42 levels [92]. Here, PRL is linked to early-onset autosomal dominant Alzheimer disease.